IT1291932B1 - Composizioni farmaceutiche antitumorali capaci anche di ridurre la farmacoresistenza in cellule tumorali, in particolare di carcinoma - Google Patents

Composizioni farmaceutiche antitumorali capaci anche di ridurre la farmacoresistenza in cellule tumorali, in particolare di carcinoma

Info

Publication number
IT1291932B1
IT1291932B1 IT97RM000368A ITRM970368A IT1291932B1 IT 1291932 B1 IT1291932 B1 IT 1291932B1 IT 97RM000368 A IT97RM000368 A IT 97RM000368A IT RM970368 A ITRM970368 A IT RM970368A IT 1291932 B1 IT1291932 B1 IT 1291932B1
Authority
IT
Italy
Prior art keywords
pharmaceutical compositions
cancer cells
drug resistance
reducing drug
tumor pharmaceutical
Prior art date
Application number
IT97RM000368A
Other languages
English (en)
Italian (it)
Inventor
Gennaro Ciliberto
Carlo Toniatti
Rocco Savino
Nicolo' Borsellino
Alessandro Natale D
Original Assignee
Angeletti P Ist Richerche Bio
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Angeletti P Ist Richerche Bio filed Critical Angeletti P Ist Richerche Bio
Priority to IT97RM000368A priority Critical patent/IT1291932B1/it
Publication of ITRM970368A0 publication Critical patent/ITRM970368A0/it
Priority to PCT/IT1998/000169 priority patent/WO1998058674A1/en
Priority to AU79315/98A priority patent/AU7931598A/en
Publication of ITRM970368A1 publication Critical patent/ITRM970368A1/it
Application granted granted Critical
Publication of IT1291932B1 publication Critical patent/IT1291932B1/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/204—IL-6
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5412—IL-6

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IT97RM000368A 1997-06-20 1997-06-20 Composizioni farmaceutiche antitumorali capaci anche di ridurre la farmacoresistenza in cellule tumorali, in particolare di carcinoma IT1291932B1 (it)

Priority Applications (3)

Application Number Priority Date Filing Date Title
IT97RM000368A IT1291932B1 (it) 1997-06-20 1997-06-20 Composizioni farmaceutiche antitumorali capaci anche di ridurre la farmacoresistenza in cellule tumorali, in particolare di carcinoma
PCT/IT1998/000169 WO1998058674A1 (en) 1997-06-20 1998-06-19 Anti-tumour pharmaceutical compositions capable of reducing drug resistance in tumour cells
AU79315/98A AU7931598A (en) 1997-06-20 1998-06-19 Anti-tumour pharmaceutical compositions capable of reducing drug resistance in tumour cells

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT97RM000368A IT1291932B1 (it) 1997-06-20 1997-06-20 Composizioni farmaceutiche antitumorali capaci anche di ridurre la farmacoresistenza in cellule tumorali, in particolare di carcinoma

Publications (3)

Publication Number Publication Date
ITRM970368A0 ITRM970368A0 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1997-06-20
ITRM970368A1 ITRM970368A1 (it) 1998-12-20
IT1291932B1 true IT1291932B1 (it) 1999-01-21

Family

ID=11405133

Family Applications (1)

Application Number Title Priority Date Filing Date
IT97RM000368A IT1291932B1 (it) 1997-06-20 1997-06-20 Composizioni farmaceutiche antitumorali capaci anche di ridurre la farmacoresistenza in cellule tumorali, in particolare di carcinoma

Country Status (3)

Country Link
AU (1) AU7931598A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IT (1) IT1291932B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
WO (1) WO1998058674A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL161673A0 (en) * 2004-04-29 2004-09-27 Applied Research Systems Compositions and methods for therapy of chemotherapy-induced neuropathy
ITRM20050103A1 (it) * 2005-03-10 2006-09-11 Rocco Savino Associazione di antagonisti della interleuchina 6 e farmaci antiproliferativi.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996020728A1 (en) * 1994-12-29 1996-07-11 Chugai Seiyaku Kabushiki Kaisha Antitumor agent potentiator comprising il-6 antagonist
IT1276555B1 (it) * 1995-04-28 1997-11-03 Angeletti P Ist Richerche Bio Antagonisti di interluchina-6 umana del tutto incapaci di formare un legame con gp 130, e loro uso per la preparazione di composizioni
JPH11506601A (ja) * 1995-06-07 1999-06-15 ジェン−プローブ・インコーポレーテッド サイトカインシグナル伝達物質ｇｐ１３０ｍＲＮＡに特異的なオリゴヌクレオチド

Also Published As

Publication number Publication date
ITRM970368A1 (it) 1998-12-20
ITRM970368A0 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1997-06-20
WO1998058674A1 (en) 1998-12-30
AU7931598A (en) 1999-01-04

Similar Documents

Publication Publication Date Title
ATE238812T1 (de) Voriconazol-enthaltende pharmazeutische zubereitungen
NO20002359L (no) Adenosinderivater og farmasoytisk sammensetning inneholdende derivatene
DE69900162D1 (de) Arzneimittel enthaltend Oxaliplatin
HUP0002381A3 (en) Apolipoprotein a-1 agonist peptide derivatives, complexes thereof and pharmaceutical compositions comprising their
HUP0102372A3 (en) Dihydropyrimidines, preparation thereof and pharmaceutical compositions containing the same
ATE279193T1 (de) Pharmazeutische zubereitung von moxifloxacin
IT1308059B1 (it) Sopporto di substrato composito, in particolare di fette o dischi
EE9900179A (et) Konjugaatide kasutamine eesnäärmevähi ravimites
AU9018898A (en) Phosphazole-containing nucleoside analogs, related compounds, pharmaceutical compositions thereof, and their use in in vitro medicinal treatments
DE69900561D1 (de) Pharmazeutische Zusammensetzungen enthaltend Mupirocin
AU1453301A (en) Methods of reversing drug resistance in cancer cells
IT1291932B1 (it) Composizioni farmaceutiche antitumorali capaci anche di ridurre la farmacoresistenza in cellule tumorali, in particolare di carcinoma
ATE260094T1 (de) Mikronisierte bicyclische arzneistoffe enthaltende pharmazeutische zusammensetzungen
ITFI990254A0 (it) Metodo diagnostico per il riconoscimento di cellule mieloidi normali e leucemiche, lignadi utilizzati in detto metodo e formulazioni ad uso
EE04316B1 (et) Asolotriasiinid ja -pürimidiinid, neid sisaldavadfarmatseutilised kompositsioonid ning nende kasutamine ravimite valmistamiseks
FR2760457B1 (fr) Nouvelles diphosphines de 6,6'-bis-(1-phosphanorbornadiene), leur preparation et leurs applications
IL161046A0 (en) Isogenic human cancer cells, methods utilizing the same for drug screening and discovery and pharmaceutical compositions containing cytidine analogs
FR2576897B1 (fr) Nouveaux derives epoxydiques, leur preparation et leur application, notamment comme medicaments antitumoraux
IT1283608B1 (it) Composizione farmaceutica per la terapia orale diuretica ed antiipertensiva.
IT8820618A0 (it) Forma farmaceutica e supporto per la somministrazione di estratti ellergenici.
FR2772764B1 (fr) Nouveaux inhibiteurs de farnesyle transferase, leur preparation, les compositions pharmaceutiques qui les contiennent et leur utilisation pour la preparation de medicaments
FI965166A0 (fi) Uusia kasvaimen- ja leukemianvastaisia aineita, niiden valmistus ja niitä sisältäviä farmaseuttisia koostumuksia
WO2003013591A3 (en) Pharmaceutical composition containing caspase-8 and/or caspase-9 useful for overcoming glucocorticoid- and cancer therapy-induced apoptosis resistance of tumours
ITMI20010009A0 (it) Composizioni farmaceutica contenente brivudina per la singola somministrazione giornaliera
ITRM990580A0 (it) Metodo per l'eradicazione selettiva di cellule tumorali aventi la funzione di p53 inattiva.

Legal Events

Date Code Title Description
0001 Granted